Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-97489 in Healthy Adult Participants
Clinical trial NCT05099822 · TERMINATED
Trial details
- NCT number
- NCT05099822
- Sponsor
- Celgene
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-13
- Primary completion
- 2022-07-11
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.